Related Experiment Video

Updated: Jul 20, 2026

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

Treatment of chronic myeloid leukemia with repeated single doses of busulfan

J R Sullivan, T H Hurley, J H Bolton

    Cancer Treatment Reports
    |January 1, 1977
    PubMed

    Abstract:

    Repeated single doses of busulfan (50-200 mg) were given over 1--2 days to 17 patients with chronic myeloid leukemia. The mean survival time was 137 weeks. In this small trial the drug was shown to be safe in most but not all patients and as effective as continous busulfan.

    More Related Videos

    Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
    08:00

    Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

    Published on: May 26, 2021

    Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
    06:08

    Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

    Published on: February 10, 2023

    Related Experiment Videos

    Last Updated: Jul 20, 2026

    Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
    11:25

    Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

    Published on: April 1, 2015

    Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
    08:00

    Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

    Published on: May 26, 2021

    Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
    06:08

    Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

    Published on: February 10, 2023

    Related Concept Videos

    Bone Marrow Sampling and Transplants01:22

    Bone Marrow Sampling and Transplants

    Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
    The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

    Articles linked to this work by shared authors, journal, and citation graph.

    The Digestive Diverticula in the Carnivorous Nudibranch, Melibe leonina, Do Not Contain Photosynthetic Symbionts.

    Integrative organismal biology (Oxford, England)·2021

    Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status?

    Internal medicine journal·2011

    Combining etanercept with traditional agents in the treatment of psoriasis: a review of the clinical evidence.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2010

    C57BL/6J mice exhibit reduced dopamine D3 receptor-mediated locomotor-inhibitory function relative to DBA/2J mice.

    Neuroscience·2006

    Development of father-infant attachment in fathers of preterm infants.

    Neonatal network : NN·2000

    Integrating the creative arts into a midwifery curriculum: a teaching innovation report.

    Nurse education today·2000

    Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.

    Cancer treatment reports·1987

    IV melphalan in children.

    Cancer treatment reports·1987

    Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.

    Cancer treatment reports·1987

    Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.

    Cancer treatment reports·1987

    Doxorubicin distribution in human breast cancer.

    Cancer treatment reports·1987

    Phase I study of echinomycin.

    Cancer treatment reports·1987

    Integrated evaluation of umbilical cord mesenchymal stromal cell-derived extracellular vesicles across skin-related cellular and zebrafish models.

    Frontiers in bioengineering and biotechnology·2026

    Effect of BMI-stratified management based on the meridian-lymph axis theory on lower extremity lymphedema after gynecological cancer surgery: a randomized controlled trial.

    Frontiers in oncology·2026

    Toxicoproteomics of APAP-exposed HepG2 cells identifies candidate translational biomarkers of liver injury and recovery.

    Frontiers in pharmacology·2026

    [KMT2A-rearranged acute lymphoblastic leukemia with lineage switch following relapse: a case report and literature review].

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026

    Notation System for Liver Transplant Recipients: Key Information in Transplant Procedure.

    Journal of hepato-biliary-pancreatic sciences·2026

    Confocal Ex Vivo Margin Assessment in Transoral Laser Cordectomy: A Pilot Diagnostic Accuracy Study.

    The Laryngoscope·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us